Which stock is a better buy right now, Pfizer (PFE) or Merck (MRK)? In this video, I analyze both firms’ balance sheets, profitability, and growth. Using an intrinsic valuation model, I determine which stock is a better buy, PFE or MRK.
0:00 – Introduction to PFE and MRK
1:00 – PFE vs. MRK Balance Sheet and DuPont Analysis
3:24 – PFE vs. MRK Dividends
4:35 – PFE vs. MRK Intrinsic Value Using Gordon Dividend Growth Model
8:04 – PFE vs. MRK Insider Trading and Conclusion
Liabilities-to-Assets Ratio = Total Liabilities / Total Assets
Current Ratio = Current Assets / Current Liabilities
Quick Ratio = (Current Assets – Inventory) / Current Liabilities
Interest Coverage Ratio = (Earnings before Interest and Taxes) / Income Tax Expense
Dividend Yield = Dividends Paid / Net Income
Payout Ratio = Dividends paid / Net Income
Modified Payout Ratio = (Dividends paid + Share buybacks) / Net Income
DuPont Analysis Video: https://www.youtube.com/watch?v=hJ0jhTn3XhY
Balance Sheet Ratios Video: https://www.youtube.com/watch?v=fXpgZTjBQlo
****** Disclaimer ********
This content is for entertainment and education purposes only. Dr. Dan does not provide investment advice. The information in this video is being presented may not be suitable for all investors as it does not consider individual investor risk tolerance levels, investment goals, or financial circumstances. Past performance may not be a reliable indicator of future performance.
powered by Auto Youtube Summarize
